Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary objective is to assess safety of rituximab combined with leflunomide. Safety will be evaluated by the frequency of Adverse Events and the outcome of laboratory blood monitoring.
Critère d'inclusion
- active rheumatoid arthritis